ModivCare Inc. (MODV)
USD 1.46
(5.8%)
USD 1.46
(5.8%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.61 Billion USD | 1.34% |
| 2022 | 1.58 Billion USD | -3.9% |
| 2021 | 1.65 Billion USD | 63.08% |
| 2020 | 1.01 Billion USD | 400.47% |
| 2019 | 202.66 Million USD | 10.23% |
| 2018 | 183.85 Million USD | -36.72% |
| 2017 | 290.52 Million USD | -8.97% |
| 2016 | 319.15 Million USD | -53.49% |
| 2015 | 686.26 Million USD | -27.29% |
| 2014 | 943.83 Million USD | 244.31% |
| 2013 | 274.12 Million USD | 0.39% |
| 2012 | 273.05 Million USD | 1.12% |
| 2011 | 270.03 Million USD | -9.44% |
| 2010 | 298.18 Million USD | -7.04% |
| 2009 | 320.76 Million USD | -2.14% |
| 2008 | 327.77 Million USD | -9.87% |
| 2007 | 363.67 Million USD | 992.82% |
| 2006 | 33.27 Million USD | -11.88% |
| 2005 | 37.76 Million USD | 233.55% |
| 2004 | 11.32 Million USD | 18.5% |
| 2003 | 9.55 Million USD | -67.54% |
| 2002 | 29.43 Million USD | -98.15% |
| 2001 | 1.58 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.62 Billion USD | 1.06% |
| 2024 Q2 | 1.66 Billion USD | 2.36% |
| 2023 Q3 | 1.6 Billion USD | -1.19% |
| 2023 Q1 | 1.59 Billion USD | 0.04% |
| 2023 Q4 | 1.61 Billion USD | 0.43% |
| 2023 FY | 1.61 Billion USD | 1.34% |
| 2023 Q2 | 1.62 Billion USD | 2.08% |
| 2022 FY | 1.58 Billion USD | -3.9% |
| 2022 Q1 | 1.73 Billion USD | 5.0% |
| 2022 Q2 | 1.67 Billion USD | -3.41% |
| 2022 Q3 | 1.63 Billion USD | -2.5% |
| 2022 Q4 | 1.58 Billion USD | -2.81% |
| 2021 Q1 | 1.11 Billion USD | 9.73% |
| 2021 Q2 | 1.16 Billion USD | 4.84% |
| 2021 Q3 | 1.73 Billion USD | 48.35% |
| 2021 FY | 1.65 Billion USD | 63.08% |
| 2021 Q4 | 1.65 Billion USD | -4.45% |
| 2020 Q1 | 391.63 Million USD | 93.24% |
| 2020 Q3 | 381.56 Million USD | 32.22% |
| 2020 Q2 | 288.57 Million USD | -26.32% |
| 2020 FY | 1.01 Billion USD | 400.47% |
| 2020 Q4 | 1.01 Billion USD | 165.82% |
| 2019 Q4 | 202.66 Million USD | -9.38% |
| 2019 FY | 202.66 Million USD | 10.23% |
| 2019 Q1 | 221.06 Million USD | 20.24% |
| 2019 Q2 | 211.35 Million USD | -4.39% |
| 2019 Q3 | 223.65 Million USD | 5.82% |
| 2018 Q2 | 310.87 Million USD | -3.35% |
| 2018 Q3 | 326.72 Million USD | 5.1% |
| 2018 Q4 | 183.85 Million USD | -43.73% |
| 2018 FY | 183.85 Million USD | -36.72% |
| 2018 Q1 | 321.64 Million USD | 10.71% |
| 2017 Q4 | 290.52 Million USD | -11.22% |
| 2017 Q2 | 319.64 Million USD | -6.73% |
| 2017 FY | 290.52 Million USD | -8.97% |
| 2017 Q1 | 342.7 Million USD | 7.38% |
| 2017 Q3 | 327.24 Million USD | 2.38% |
| 2016 Q3 | 709.95 Million USD | 1.04% |
| 2016 Q4 | 319.15 Million USD | -55.05% |
| 2016 FY | 319.15 Million USD | -53.49% |
| 2016 Q1 | 677.34 Million USD | -1.3% |
| 2016 Q2 | 702.61 Million USD | 3.73% |
| 2015 Q1 | 892.73 Million USD | -5.41% |
| 2015 FY | 686.26 Million USD | -27.29% |
| 2015 Q4 | 686.26 Million USD | -22.33% |
| 2015 Q2 | 896.23 Million USD | 0.39% |
| 2015 Q3 | 883.62 Million USD | -1.41% |
| 2014 Q1 | 277.31 Million USD | 1.16% |
| 2014 Q2 | 486.19 Million USD | 75.32% |
| 2014 FY | 943.83 Million USD | 244.31% |
| 2014 Q4 | 943.83 Million USD | 95.8% |
| 2014 Q3 | 482.03 Million USD | -0.86% |
| 2013 Q1 | 280.77 Million USD | 2.83% |
| 2013 Q4 | 274.12 Million USD | -1.77% |
| 2013 Q3 | 279.06 Million USD | -0.93% |
| 2013 FY | 274.12 Million USD | 0.39% |
| 2013 Q2 | 281.67 Million USD | 0.32% |
| 2012 Q2 | 284.14 Million USD | 2.88% |
| 2012 Q4 | 273.05 Million USD | -4.85% |
| 2012 FY | 273.05 Million USD | 1.12% |
| 2012 Q1 | 276.19 Million USD | 2.28% |
| 2012 Q3 | 286.97 Million USD | 1.0% |
| 2011 Q3 | 275.82 Million USD | -4.7% |
| 2011 FY | 270.03 Million USD | -9.44% |
| 2011 Q4 | 270.03 Million USD | -2.1% |
| 2011 Q2 | 289.42 Million USD | -1.12% |
| 2011 Q1 | 292.69 Million USD | -1.84% |
| 2010 Q1 | 321.53 Million USD | 0.24% |
| 2010 FY | 298.18 Million USD | -7.04% |
| 2010 Q4 | 298.18 Million USD | -5.29% |
| 2010 Q3 | 314.84 Million USD | 0.21% |
| 2010 Q2 | 314.16 Million USD | -2.29% |
| 2009 FY | 320.76 Million USD | -2.14% |
| 2009 Q1 | 328.28 Million USD | 0.16% |
| 2009 Q2 | 328.26 Million USD | -0.01% |
| 2009 Q3 | 339.18 Million USD | 3.33% |
| 2009 Q4 | 320.76 Million USD | -5.43% |
| 2008 FY | 327.77 Million USD | -9.87% |
| 2008 Q4 | 327.77 Million USD | -7.21% |
| 2008 Q3 | 353.24 Million USD | 1.6% |
| 2008 Q2 | 347.69 Million USD | -4.88% |
| 2008 Q1 | 365.51 Million USD | 0.51% |
| 2007 FY | 363.67 Million USD | 992.82% |
| 2007 Q4 | 363.67 Million USD | 664.54% |
| 2007 Q2 | 33.62 Million USD | -1.36% |
| 2007 Q1 | 34.08 Million USD | 2.42% |
| 2007 Q3 | 47.56 Million USD | 41.48% |
| 2006 Q4 | 33.27 Million USD | 34.36% |
| 2006 Q3 | 24.76 Million USD | -5.38% |
| 2006 Q2 | 26.17 Million USD | -31.65% |
| 2006 FY | 33.27 Million USD | -11.88% |
| 2006 Q1 | 38.3 Million USD | 1.41% |
| 2005 Q3 | 37.42 Million USD | 50.08% |
| 2005 Q2 | 24.93 Million USD | 103.2% |
| 2005 Q1 | 12.27 Million USD | 8.38% |
| 2005 Q4 | 37.76 Million USD | 0.92% |
| 2005 FY | 37.76 Million USD | 233.55% |
| 2004 Q3 | 11.91 Million USD | 53.32% |
| 2004 Q2 | 7.77 Million USD | -8.4% |
| 2004 Q1 | 8.48 Million USD | -11.17% |
| 2004 Q4 | 11.32 Million USD | -5.01% |
| 2004 FY | 11.32 Million USD | 18.5% |
| 2003 Q4 | 9.55 Million USD | -11.75% |
| 2003 FY | 9.55 Million USD | -67.54% |
| 2003 Q3 | 10.82 Million USD | -71.28% |
| 2003 Q2 | 37.7 Million USD | 0.0% |
| 2002 FY | 29.43 Million USD | -98.15% |
| 2001 Q4 | 1.58 Billion USD | 0.0% |
| 2001 FY | 1.58 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 34.805% |
| Addus HomeCare Corporation | 317.73 Million USD | -407.056% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -1143.501% |
| Amedisys, Inc. | 940.38 Million USD | -71.321% |
| Astrana Health, Inc. | 522.59 Million USD | -208.286% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 8.7% |
| IMAC Holdings, Inc. | 1.89 Million USD | -84838.258% |
| biote Corp. | 191.84 Million USD | -739.8% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -2129.807% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | -682.366% |
| COMPASS Pathways plc | 50.24 Million USD | -3106.576% |
| DocGo Inc. | 185.28 Million USD | -769.533% |
| The Ensign Group, Inc. | 2.68 Billion USD | 39.89% |
| Healthcare Services Group, Inc. | 346.56 Million USD | -364.87% |
| InnovAge Holding Corp. | 247.85 Million USD | -550.014% |
| The Joint Corp. | 62.37 Million USD | -2482.729% |
| LifeStance Health Group, Inc. | 804.27 Million USD | -100.314% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -42172.672% |
| NewGenIvf Group Limited | 1.24 Million USD | -129675.623% |
| Option Care Health, Inc. | 1.9 Billion USD | 15.503% |
| P3 Health Partners Inc. | 427.3 Million USD | -277.033% |
| P3 Health Partners Inc. | 427.3 Million USD | -277.033% |
| The Pennant Group, Inc. | 394.17 Million USD | -308.721% |
| Surgery Partners, Inc. | 3.65 Billion USD | 55.948% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -176927.752% |
| Talkspace, Inc. | 23.57 Million USD | -6733.849% |
| Talkspace, Inc. | 23.57 Million USD | -6733.849% |
| The Oncology Institute, Inc. | 162.39 Million USD | -892.087% |
| The Oncology Institute, Inc. | 162.39 Million USD | -892.087% |